Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Poliovirus"" wg kryterium: Temat


Tytuł :
Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey.
Autorzy :
Xu J; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, China.
Wang Q; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, China.
Kuang S; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, China.
Rong R; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, China.
Zhang Y; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, China.
Fu X; Department of Pharmaceutical Trade and Management, Chongqing Medical and Pharmaceutical College, Chongqing, China.
Tang W; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, China.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2125-2131. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Poliomyelitis*/prevention & control
Poliovirus*
Antibodies, Viral ; Child ; China ; Cross-Sectional Studies ; Humans ; Immunization Schedule ; Infant ; Poliovirus Vaccine, Inactivated ; Poliovirus Vaccine, Oral ; Vaccination
Czasopismo naukowe
Tytuł :
Detection of vaccine-derived poliovirus circulation by environmental surveillance in the absence of clinical cases.
Autorzy :
Odoom JK; Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Obodai E; Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Boateng G; Public Health and Reference Laboratory, Ghana Health Service, Accra, Ghana.
Diamenu S; World Health Organization, Country Office, Accra, Ghana.
Attiku K; Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Avevor P; Ghana Health Service, Private Mail Bag, Ministries, Accra, Ghana.
Duker E; Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Boahene B; Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Eshun M; Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Gberbie E; Noguchi Memorial Institute of Medical Research, University of Ghana, Legon, Ghana.
Opare JKL; Ghana Health Service, Private Mail Bag, Ministries, Accra, Ghana.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2117-2124. Date of Electronic Publication: 2021 Jan 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*
Child ; Environmental Monitoring ; Ghana ; Humans ; Nigeria ; Poliovirus Vaccine, Oral
Czasopismo naukowe
Tytuł :
Poliovirus excretion among children with primary immune deficiency in Pakistan: a pilot surveillance study protocol.
Autorzy :
Pethani AS; Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Kazi Z; Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Nayyar U; Polio Eradication Initiative, World Health Organization Country Office for Pakistan, Islamabad, Pakistan.
Shafiq-Ur-Rehman M; Polio Eradication Initiative, World Health Organization Country Office for Pakistan, Islamabad, Pakistan.
Yousafzai MT; Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Ondrej M; Polio Department, World Health Organization, Geneva, Switzerland.
Saleem AF; Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan .
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 Jul 28; Vol. 11 (7), pp. e045904. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*
Primary Immunodeficiency Diseases*
Child ; Humans ; Pakistan/epidemiology ; Poliovirus Vaccine, Oral/adverse effects
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults.
Autorzy :
Leroux-Roels I; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium.
Leroux-Roels G; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium.
Shukarev G; Janssen Vaccines AG, Bern, Switzerland.
Schuitemaker H; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
Cahill C; Takeda Pharmaceuticals, Zurich, Switzerland.
de Rooij R; Takeda Pharmaceuticals, Zurich, Switzerland.
Struijs M; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
van Zeeburg H; DCPrime BV, Leiden the Netherlands.
Jacquet JM; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 May 04; Vol. 17 (5), pp. 1366-1373. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Poliomyelitis*
Poliovirus*
Adult ; Antibodies, Viral ; Belgium ; Cell Line ; Humans ; Immunogenicity, Vaccine ; Poliovirus Vaccine, Inactivated ; Poliovirus Vaccine, Oral
Czasopismo naukowe
Tytuł :
Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement.
Autorzy :
Chen H; China National Biotec Group Company Limited, Beijing, China.
Gao Z; Tianjin Centers for Disease Control and Prevention, Tianjin, China.
Bai S; Beijing Center for Diseases and Prevention Control, Beijing, China.
Liu X; China National Biotec Group Company Limited, Beijing, China.
Han S; China National Biotec Group Company Limited, Beijing, China.
Xiao Y; China National Biotec Group Company Limited, Beijing, China.
Liu F; Beijing Chaoyang District Center for Diseases and Prevention Control, Beijing, China.
Yu Y; Tianjin Jinghai District Center for Disease Control and Prevention, Tianjin, China.
Sun H; Tianjin Jinghai District Center for Disease Control and Prevention, Tianjin, China.
Yang X; China National Biotec Group Company Limited, Beijing, China. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Apr 22; Vol. 39 (17), pp. 2467-2474. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Poliomyelitis*/prevention & control
Poliovirus*
Antibodies, Viral ; China ; Humans ; Immunization Schedule ; Immunogenicity, Vaccine ; Infant ; Poliovirus Vaccine, Inactivated/adverse effects ; Poliovirus Vaccine, Oral
Czasopismo naukowe
Tytuł :
Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
Autorzy :
Bianchi FP; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Larocca AMV; Hygiene Department, Bari Policlinico General Hospital, Bari, Italy.
Bozzi A; Hygiene Department, Bari Policlinico General Hospital, Bari, Italy.
Spinelli G; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Germinario CA; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Tafuri S; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy. Electronic address: .
Stefanizzi P; Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 May 21; Vol. 39 (22), pp. 2989-2994. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*
Antibodies, Neutralizing ; Antibodies, Viral ; Child ; Humans ; Italy/epidemiology ; Poliovirus Vaccine, Inactivated ; Poliovirus Vaccine, Oral ; Retrospective Studies ; Seroepidemiologic Studies
Czasopismo naukowe
Tytuł :
Stopping a polio outbreak in the midst of war: Lessons from Syria.
Autorzy :
Mbaeyi C; United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA. Electronic address: .
Moran T; World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.
Wadood Z; World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.
Ather F; Middle East and North Africa Office, United Nations Children's Fund, Abdulqader Al-Abed Street, Building No. 15, Tla'a Al-Ali, Amman, Jordan.
Sykes E; World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.
Nikulin J; World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.
Al Safadi M; World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.
Stehling-Ariza T; United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA.
Zomahoun L; World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.
Ismaili A; World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.
Abourshaid N; Syria Country Office, United Nations Children's Fund, East Mazzeh, Al Shafiee St., Damascus, Syria.
Asghar H; World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.
Korukluoglu G; Public Health Institutions of Turkey, Adnan Saygun Cad. No. 55, F Blok 06100 Sihhiye, Ankara, Turkey.
Duizer E; National Polio Laboratory, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA, Bilthoven, the Netherlands.
Ehrhardt D; United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA.
Burns CC; United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA.
Sharaf M; World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 23; Vol. 39 (28), pp. 3717-3723. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*
Child ; Disease Outbreaks ; Humans ; Poliovirus Vaccine, Oral ; Syria/epidemiology
Czasopismo naukowe
Tytuł :
Coordinated Response to Imported Vaccine-Derived Poliovirus Infection, Barcelona, Spain, 2019-2020.
Autorzy :
Álamo-Junquera D
Politi J
Simón P
Dieli-Crimi R
Borrell RP
Colobran R
Martínez-Gallo M
Campins M
Antón A
Esperalba J
Andrés C
Codina MG
Polverino E
Narciso MR
Molinero E
Rius C
Pokaż więcej
Źródło :
Emerging infectious diseases [Emerg Infect Dis] 2021 May; Vol. 27 (5), pp. 1513-1516.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*
Poliovirus*
Disease Eradication ; Humans ; Poliovirus Vaccine, Oral ; Spain
Czasopismo naukowe
Tytuł :
Quantifying movement patterns and vaccination status of high risk mobile populations in Pakistan and Afghanistan to inform poliovirus risk and vaccination strategy.
Autorzy :
Molodecky NA; World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan; Department of Infectious Disease Epidemiology, Imperial College London, London, UK. Electronic address: .
Usman A; World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan.
Javaid A; World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan.
Wahdan A; World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan; World Health Organization (WHO), EMRO, Amman, Jordan.
Parker EPK; The Vaccine Centre, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Ahmed JA; World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan; World Health Organization (WHO), Geneva, Switzerland.
Shah N; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan.
Agbor J; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan; UNICEF, Islamabad, Pakistan.
Mahamud A; World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan; World Health Organization (WHO), Geneva, Switzerland.
Safdar RM; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan; Ministry of National Health Services, Regulations and Coordination, Islamabad, Pakistan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Apr 08; Vol. 39 (15), pp. 2124-2132. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*
Afghanistan/epidemiology ; Child ; Humans ; Immunization Programs ; Infant ; Pakistan/epidemiology ; Poliovirus Vaccine, Oral ; Vaccination
Czasopismo naukowe
Tytuł :
Physicochemical Characterization of Sabin Inactivated Poliovirus Vaccine for Process Development.
Autorzy :
Torisu T; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan. Electronic address: .
Shikama S; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan.
Nakamura K; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan.
Enomoto K; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Maruno T; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Mori A; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Uchiyama S; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Satou T; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan.
Pokaż więcej
Źródło :
Journal of pharmaceutical sciences [J Pharm Sci] 2021 May; Vol. 110 (5), pp. 2121-2129. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*
Poliovirus*
Humans ; Poliovirus Vaccine, Inactivated ; Surface Plasmon Resonance ; Virion
Czasopismo naukowe
Tytuł :
Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.
Autorzy :
Li J; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.; Department of Immunization and Prevention, Beijing Center for Disease Control and Prevention , Beijing, PR China.
Zhang Z; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.
Zhang H; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.
Li M; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.
Li X; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.
Lu L; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.
Huang F; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.
Wu J; Department of Immunization and Prevention, Beijing Research Centre for Preventive Medicine , Beijing, PR China.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Feb 01; Vol. 17 (2), pp. 389-396. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*
Poliovirus Vaccines*
Antibodies, Viral ; Beijing ; China/epidemiology ; Cross-Sectional Studies ; Humans ; Infant ; Poliovirus Vaccine, Inactivated ; Poliovirus Vaccine, Oral ; Seroepidemiologic Studies ; Vaccination
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Autorzy :
De Coster I; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Leroux-Roels I; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium.
Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Gast C; PATH, Washington DC, USA.
Withanage K; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Steenackers K; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
De Smedt P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Aerssens A; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium.
Leroux-Roels G; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium.
Oberste MS; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Konopka-Anstadt JL; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Weldon WC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Fix A; PATH, Washington DC, USA.
Konz J; PATH, Washington DC, USA.
Wahid R; PATH, Washington DC, USA.
Modlin J; Bill & Melinda Gates Foundation, Seattle, WA, USA; PATH, Washington DC, USA; Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Clemens R; Global Research in Infectious Diseases, Rio de Janeiro, Brazil.
Costa Clemens SA; Institute for Global Health, Siena University, Siena, Italy.
Bachtiar NS; PT Bio Farma, Bandung, Indonesia.
Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jan 02; Vol. 397 (10268), pp. 39-50. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Clinical Trial, Phase II; Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunogenicity, Vaccine*
Poliovirus*/genetics
Poliovirus*/immunology
Poliomyelitis/*prevention & control
Poliovirus Vaccine, Oral/*adverse effects
Poliovirus Vaccine, Oral/*immunology
Adult ; Belgium ; Female ; Humans ; Male ; Middle Aged ; Poliovirus Vaccine, Oral/administration & dosage ; Vaccination
Czasopismo naukowe
Tytuł :
[Advances in researches of serotype 2 novel oral polio vaccine].
Autorzy :
Chen SY; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
Li Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
Yang JS; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
Yin XX; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
Pokaż więcej
Źródło :
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] [Zhonghua Yu Fang Yi Xue Za Zhi] 2021 Mar 06; Vol. 55 (3), pp. 413-417.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*/genetics
Africa ; Asia ; Disease Eradication ; Global Health ; Humans ; Poliovirus Vaccine, Inactivated ; Poliovirus Vaccine, Oral ; Serogroup
Czasopismo naukowe
Tytuł :
Vaccine-Derived Polioviruses, Central African Republic, 2019.
Autorzy :
Joffret ML
Doté JW
Gumede N
Vignuzzi M
Bessaud M
Gouandjika-Vasilache I
Pokaż więcej
Źródło :
Emerging infectious diseases [Emerg Infect Dis] 2021 Feb; Vol. 27 (2), pp. 620-623.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*/genetics
Central African Republic/epidemiology ; Child ; Disease Outbreaks ; Humans ; Poliovirus Vaccine, Oral/adverse effects
Czasopismo naukowe
Tytuł :
"Does Pakistan still have polio cases?": Exploring discussions on polio and polio vaccine in online news comments in Pakistan.
Autorzy :
Ittefaq M; William Allen White School of Journalism and Mass Communications, University of Kansas, Lawrence, KS, United States. Electronic address: .
Baines A; William Allen White School of Journalism and Mass Communications, University of Kansas, Lawrence, KS, United States.
Abwao M; William Allen White School of Journalism and Mass Communications, University of Kansas, Lawrence, KS, United States.
Shah SFA; Department of Communication, Jacksonville State University, Jacksonville, Alabama, United States.
Ramzan T; Lahore Business School, University of Lahore, Lahore, Pakistan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jan 15; Vol. 39 (3), pp. 480-486. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*/epidemiology
Poliomyelitis*/prevention & control
Poliovirus*
Poliovirus Vaccines*
Child ; Disease Eradication ; Humans ; Immunization Programs ; Pakistan/epidemiology ; Poliovirus Vaccine, Oral ; Vaccination
Czasopismo naukowe
Tytuł :
The Long and Winding Road to Eradicate Vaccine-Related Polioviruses.
Autorzy :
Cochi SL; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pallansch MA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Jan 04; Vol. 223 (1), pp. 7-9.
Typ publikacji :
Editorial; Research Support, U.S. Gov't, P.H.S.; Comment
MeSH Terms :
Poliomyelitis*/prevention & control
Poliovirus*/immunology
Child ; Humans ; Lithuania ; Poliovirus Vaccine, Inactivated ; Poliovirus Vaccine, Oral
Raport
Tytuł :
Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis.
Autorzy :
Mashunye TR; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address: .
Ndwandwe DE; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Dube KR; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Shey M; Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Disease Research in Africa (CIDRI-Africa), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Shelton M; Health Sciences Library, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Wiysonge CS; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Aug; Vol. 21 (8), pp. 1161-1174. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Immunization Schedule*
Immunogenicity, Vaccine*
Antibodies, Viral/*blood
Poliovirus Vaccine, Inactivated/*administration & dosage
Administration, Oral ; Child, Preschool ; Dose-Response Relationship, Immunologic ; Humans ; Injections, Intradermal ; Poliomyelitis/prevention & control ; Poliovirus ; Poliovirus Vaccine, Inactivated/immunology ; Randomized Controlled Trials as Topic ; Seroconversion
Czasopismo naukowe
Tytuł :
Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population.
Autorzy :
Jiang R; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China; Yunnan Key Laboratory of Vaccine Research and Development on Severe Infections Diseases, Kunming, Yunnan, China.
Liu X; Vaccine Clinical Research Center, Yunnan Center for Disease Control and Prevention, Kunming, Yunnan, China.
Sun X; Shanghai Center for Disease Control and Prevention, Shanghai, China. Electronic address: .
Wang J; Division of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
Huang Z; Shanghai Center for Disease Control and Prevention, Shanghai, China. Electronic address: .
Li C; Division of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
Li Z; Shanghai Center for Disease Control and Prevention, Shanghai, China. Electronic address: .
Zhou J; Mile Center for Disease Control and Prevention, Mile, Yunnan, China.
Pu Y; Gejiu Center for Disease Control and Prevention, Gejiu, Yunnan, China.
Ying Z; Division of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
Yin Q; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China.
Zhao Z; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China.
Zhang L; Vaccine Clinical Research Center, Yunnan Center for Disease Control and Prevention, Kunming, Yunnan, China.
Lei J; Gejiu Center for Disease Control and Prevention, Gejiu, Yunnan, China.
Bao W; Gejiu Center for Disease Control and Prevention, Gejiu, Yunnan, China.
Jiang Y; Mile Center for Disease Control and Prevention, Mile, Yunnan, China.
Dou Y; Mile Center for Disease Control and Prevention, Mile, Yunnan, China.
Li J; Vaccine Clinical Research Center, Yunnan Center for Disease Control and Prevention, Kunming, Yunnan, China.
Yang H; Vaccine Clinical Research Center, Yunnan Center for Disease Control and Prevention, Kunming, Yunnan, China.
Cai W; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China; Yunnan Key Laboratory of Vaccine Research and Development on Severe Infections Diseases, Kunming, Yunnan, China. Electronic address: .
Deng Y; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China. Electronic address: .
Che Y; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China. Electronic address: .
Shi L; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China. Electronic address: .
Sun M; Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China; Yunnan Key Laboratory of Vaccine Research and Development on Severe Infections Diseases, Kunming, Yunnan, China. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Mar 01; Vol. 39 (9), pp. 1463-1471. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Poliomyelitis*/prevention & control
Poliovirus Vaccine, Oral*/adverse effects
Antibodies, Viral ; China ; Humans ; Immunogenicity, Vaccine ; Infant ; Poliovirus Vaccine, Inactivated/adverse effects ; Vaccination
Czasopismo naukowe
Tytuł :
Mutation, Selection, and Bottlenecks in Polio Vaccine Reversion.
Autorzy :
Ebel GD; Center for Vector-Borne Infectious Diseases, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell host & microbe [Cell Host Microbe] 2021 Jan 13; Vol. 29 (1), pp. 3-5.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Poliomyelitis*/prevention & control
Poliovirus*/genetics
Humans ; Mutation ; Poliovirus Vaccine, Oral ; Vaccination
Czasopismo naukowe
Tytuł :
An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan.
Autorzy :
Bullo UF; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.
Mehraj J; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan. .; Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi, Sindh, Pakistan. .
Raza SM; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.; The United Nations Children's Fund (UNICEF), Karachi, Sindh, Pakistan.
Rasool S; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.; National Stop Transmission of Polio (N-STOP) Program, Karachi, Sindh, Pakistan.
Ansari NN; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.
Shaikh AA; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.; Bill and Melinda Gates Foundation, Karachi, Sindh, Pakistan.
Phul ZA; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.; National Stop Transmission of Polio (N-STOP) Program, Karachi, Sindh, Pakistan.
Memon SA; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.; National Stop Transmission of Polio (N-STOP) Program, Karachi, Sindh, Pakistan.
Baloch RI; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.
Baloch ZA; Expanded Program on Immunization, Government of Sindh, Karachi, Sindh, Pakistan.
Chandio SA; Emergency Operations Centre for Polio Eradication and Immunization, Government of Sindh, Karachi, Sindh, Pakistan.; The United Nations Children's Fund (UNICEF), Karachi, Sindh, Pakistan.
Pokaż więcej
Źródło :
BMC public health [BMC Public Health] 2021 Jan 06; Vol. 21 (1), pp. 44. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article
MeSH Terms :
Poliomyelitis*/prevention & control
Poliovirus*
Child ; Humans ; Infant ; Injections, Intradermal ; Mass Drug Administration ; Pakistan ; Poliovirus Vaccine, Inactivated ; Vaccination
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies